Table 4.
Number (%) of patients who ever received therapeutic or palliative surgery, by deprivation status
| Distribution of affluence (tenths) | No (%) who received surgery | % difference from most affluent 10th (95% CI) | Odds of ever receiving surgery (95% CI) |
|---|---|---|---|
| Colorectal cancer (ICD-9 codes 153-154) | |||
| 1st (affluent) | 1456/2606 (55.87) | 1.00 | |
| 2nd | 1549/2774 (55.84) | −0.03 (−2.69 to 2.62) | 1.00 (0.89 to 1.11) |
| 3rd | 1638/2859 (57.29) | 1.42 (−1.21 to 4.05) | 1.05 (0.94 to 1.17) |
| 4th | 1557/2832 (54.98) | −0.89 (−3.54 to 1.75) | 0.96 (0.86 to 1.07) |
| 5th | 1571/2782 (56.47) | 0.60 (−2.05 to 3.25) | 1.01 (0.91 to 1.13) |
| 6th | 1398/2521 (55.45) | −0.42 (−3.14 to 2.30) | 0.97 (0.87 to 1.09) |
| 7th | 1366/2445 (55.87) | 0.00 (−2.74 to 2.74) | 0.99 (0.89 to 1.11) |
| 8th | 1237/2153 (57.45) | 1.58 (−1.24 to 4.41) | 1.06 (0.94 to 1.19) |
| 9th | 1154/2047 (56.38) | 0.50 (−2.37 to 3.38) | 1.01 (0.90 to 1.14) |
| 10th (deprived) | 985/1869 (52.70) | −3.17 (−6.13 to −0.21) | 0.88 (0.78 to 1.00) |
| Deviance difference (trend) | 1.08 | ||
| Deviance difference (heterogeneity) | 12.31 | ||
| Unknown | 245/416 (58.89) | 3.02 (−2.07 to 8.12) | 1.14 (0.92 to 1.40) |
| Cancer of lung, trachea, or bronchus (ICD-9 code 162) | |||
| 1st (affluent) | 256/1642 (15.59) | 1.00 | |
| 2nd | 265/1976 (13.41) | −2.18 (−4.49 to 0.13) | 0.85 (0.71 to 1.03) |
| 3rd | 274/2107 (13.00) | −2.59 (−4.85 to−0.32) | 0.83 (0.69 to 1.00) |
| 4th | 287/2276 (12.61) | −2.98 (−5.20 to −0.76) | 0.80 (0.67 to 0.96) |
| 5th | 277/2382 (11.63) | −3.96 (−6.14 to −1.79) | 0.74 (0.61 to 0.89) |
| 6th | 287/2446 (11.73) | −3.86 (−6.03 to −1.69) | 0.73 (0.61 to 0.88) |
| 7th | 288/2446 (11.77) | −3.82 (−5.99 to −1.65) | 0.74 (0.62 to 0.89) |
| 8th | 333/2533 (13.15) | −2.44 (−4.64 to −0.25) | 0.82 (0.68 to 0.98) |
| 9th | 342/2595 (13.18) | −2.41 (−4.60 to −0.23) | 0.82 (0.69 to 0.98) |
| 10th (deprived) | 260/2581 (10.07) | −5.52 (−7.62 to −3.41) | 0.58 (0.48 to 0.70) |
| Deviance difference (trend) | 19.04* | ||
| Deviance difference (heterogeneity) | 39.72* | ||
| Unknown | 61/434 (14.06) | −1.54 (−5.25 to 2.18) | 0.81 (0.60 to 1.11) |
| Female breast cancer (ICD-9 code 174) | |||
| 1st (affluent) | 1927/2953 (65.26) | 1.00 | |
| 2nd | 1980/3053 (64.85) | −0.40 (−2.81 to 2.01) | 0.99 (0.89 to 1.10) |
| 3rd | 2054/3171 (64.77) | −0.48 (−2.87 to 1.91) | 0.99 (0.89 to 1.10) |
| 4th | 1980/3031 (65.32) | 0.07 (−2.34 to 2.48) | 1.02 (0.92 to 1.13) |
| 5th | 1845/2936 (62.84) | −2.42 (−4.87 to 0.04) | 0.91 (0.82 to 1.01) |
| 6th | 1727/2809 (61.48) | −3.77 (−6.26 to −1.29) | 0.86 (0.77 to 0.96) |
| 7th | 1661/2655 (62.56) | −2.69 (−5.21 to −0.18) | 0.90 (0.81 to 1.01) |
| 8th | 1472/2394 (61.49) | −3.77 (−6.37 to −1.17) | 0.86 (0.77 to 0.97) |
| 9th | 1352/2244 (60.25) | −5.01 (−7.66 to −2.35) | 0.81 (0.73 to 0.91) |
| 10th (deprived) | 1094/2025 (54.02) | −11.23 (−14.00 to −8.46) | 0.63 (0.56 to 0.71) |
| Deviance difference (trend) | 73.38* | ||
| Deviance difference (heterogeneity) | 103.67* | ||
| Unknown | 345/559 (61.72) | −3.54 (−7.92 to 0.84) | 0.85 (0.70 to 1.02) |
*
P<0.05.